Pitavastatin Calcium Tablet
FDA Label NDC 70771-1785

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Pitavastatin Calcium (NDC 70771-1785). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

Pitavastatin Tablets, 1 mg

NDC 70771-1784-9

Bottle of 90 tablets

Rx only

1 mg Label (0b3f9e08 016b 4434 Bd13 1d9d0956ae66 01)

1 mg Label (0b3f9e08 016b 4434 Bd13 1d9d0956ae66 01)

Pitavastatin Tablets, 2 mg

NDC 70771-1785-9

Bottle of 90 tablets

Rx only

2 mg Label (0b3f9e08 016b 4434 Bd13 1d9d0956ae66 02)

2 mg Label (0b3f9e08 016b 4434 Bd13 1d9d0956ae66 02)

Pitavastatin Tablets, 4 mg

NDC 70771-1786-9

Bottle of 90 tablets

Rx only

4 mg Label (0b3f9e08 016b 4434 Bd13 1d9d0956ae66 03)

4 mg Label (0b3f9e08 016b 4434 Bd13 1d9d0956ae66 03)

* Please review the disclaimer below.